This inventor holds 2 USPTO granted patents. Top assignees: Biocon Limited, Other. Active years: 2018-2020.
Company Filing History:
1 out of 112 
1 out of 834,411 Years Active: 2018-2020
Title: Kedernath Sastry: Innovator in Cancer Therapy
Introduction
Kedernath Sastry is a notable inventor based in Karnataka, India. He has made significant contributions to the field of cancer therapy through his innovative work in recombinant chimeric fusion proteins. With a total of two patents to his name, his research focuses on enhancing the efficacy and cost-effectiveness of cancer treatments.
Latest Patents
Kedernath Sastry's latest patents include the development of fusion immunomodulatory proteins and methods for making them. These inventions relate to generating recombinant chimeric fusion proteins specifically designed for cancer therapy. The patents detail fusion molecules such as Anti-EGFR1-TGFβRII, Anti-EGFR1-PD1, and Anti-CTLA4-PD1. The methods outlined in these patents aim to reduce production costs while increasing the homogeneity of the recombinant chimeric fusion proteins.
Career Highlights
Throughout his career, Kedernath has worked with Biocon Limited, a leading biopharmaceutical company in India. His experience in this prominent organization has allowed him to contribute to groundbreaking research and development in the field of biotechnology.
Collaborations
Kedernath has collaborated with several professionals in his field, including Nagaraj Govindappa and Maria Melina Soares. These collaborations have further enriched his research and innovation efforts.
Conclusion
Kedernath Sastry stands out as an influential inventor in the realm of cancer therapy. His patents and career achievements reflect his dedication to advancing medical science and improving treatment options for patients.